Showing results (941-950 of 6,317) with videos related to

Sort By:
Pageof 632
Diabetes, Obesity & Metabolism|May 10, 2019
The effects of hypoglycaemia and dementia on cardiovascular events, falls and fractures and all-cause mortality in older individuals: A retrospective cohort studyKatharina Mattishent, Kathryn Richardson, Ketan Dhatariya, et al.
Diabetes, Obesity & Metabolism|May 10, 2019
Predictors of treatment response in type-2 diabetes patients initiating basal-supported oral therapy with insulin glargine 100 U/mL: A sub-analysis of the Titration and OPtimisation (TOP) registryMartin Pfohl, Stefan Pscherer, Andreas Fritsche, et al.
Diabetes, Obesity & Metabolism|May 11, 2019
Ethnic differences in intrahepatic lipid and its association with hepatic insulin sensitivity and insulin clearance between men of black and white ethnicity with early type 2 diabetesOlah Hakim, Oluwatoyosi Bello, Riccardo C Bonadonna, et al.
Diabetes, Obesity & Metabolism|September 20, 2018
tRNA modifications and islet functionFan-Yan Wei, Kazuhito Tomizawa
Diabetes, Obesity & Metabolism|September 20, 2018
Regulation of islet glucagon secretion: Beyond calciumJing W Hughes, Alessandro Ustione, Zeno Lavagnino, et al.
Diabetes, Obesity & Metabolism|September 19, 2018
Titration and optimization trial for the initiation of insulin glargine 100 U/mL in patients with inadequately controlled type 2 diabetes on oral antidiabetic drugsJochen Seufert, Andreas Fritsche, Stefan Pscherer, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Glucagon-like peptide-1 receptor agonists and cardiovascular outcomes in patients with and without prior cardiovascular events: An updated meta-analysis and subgroup analysis of randomized controlled trialsEdoardo Mannucci, Ilaria Dicembrini, Besmir Nreu, et al.
Diabetes, Obesity & Metabolism|October 10, 2019
Comparative cardiovascular and hypoglycaemic safety of glimepiride in type 2 diabetes: A population-based cohort studyAntonios Douros, Sophie Dell'Aniello, Oriana Hoi Yun Yu, et al.
Diabetes, Obesity & Metabolism|June 29, 2017
Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatmentManel Mata-Cases, Josep Franch-Nadal, Jordi Real, et al.
Diabetes, Obesity & Metabolism|August 23, 2016
Histological changes in endocrine and exocrine pancreatic tissue from patients exposed to incretin-based therapiesSandra Ueberberg, Hendrik Jütte, Waldemar Uhl, et al.
Pageof 632